Cancer Research

Cancer Research

Breastlink is committed to working with research partners to help improve our ability to detect and treat breast cancer. Breast cancer research news from our practices

Breastlink Partners with Researchers to Explore Atezolizumab in Triple-Negative Breast Cancer Patients

Breastlink has partnered with researchers to explore an investigational cancer immunotherapy called atezolizumab (MPDL3280A) in the treatment of metastatic triple-negative breast cancer. In early-stage trials, atezolizmab was effective in patients previously treated for triple-negative breast cancer. A new trial will investigate atezolizumab with chemotherapy in metastatic triple-negative breast cancer patients who have not received prior systemic therapy for incurable disease. […]

By | October 19, 2015|Categories: Cancer Research, Oncology, Press Releases|0 Comments

ASCO 2015 Update: Releasing the Potential of the Immune System

The Annual Meeting of the American Society of Clinical Oncology (ASCO) provides an opportunity for thousands of oncologists and healthcare professionals to receive research updates and exchange ideas surrounding trends in cancer treatments. More than 30,000 attend each year, making it one of the largest educational and scientific conferences dedicated to advancing cancer care. I recently joined my colleagues for the ASCO 2015 Annual Meeting, where a focus was on breakthroughs in immunotherapy.

What is Immunotherapy?

Immunotherapy refers to treatments that prompt the human body’s immune system to attack cancer cells. Cancer occurs when a genetic mutations occurs that causes a healthy cell to become cancerous. Can the immune system recognize these […]

By | August 24, 2015|Categories: Cancer News, Cancer Research, Oncology|0 Comments

How Do Single-Gene & Multi-Gene Tests Compare?

The landscape of testing for hereditary cancer predisposition genes has been in rapid evolution. Recently developed tests can evaluate up to 43 genetic mutations associated with increased risk for a variety of cancers including breast cancer. Using data collected from our clinics, my Breastlink colleagues and I have analyzed how safe and effective these newer multi-gene tests are in comparison to previous methods of genetic testing.

Genetic Mutations breast cancer | gene tests

The Development of Multi-Gene Tests for Breast Cancer Risk

Two key events have helped change the face of genetic testing:

  • Technology became so advanced with next generation sequencing that it became as simple […]
By | April 30, 2015|Categories: Breast Cancer Screening, Cancer Research|Tags: , |6 Comments

SABCS 2014: Breast Cancer Radiation Therapy Preview

Every year, some of the world’s leading experts on breast cancer gather for the San Antonio Breast Cancer Symposium (SABCS). One of the premier forums on the subject, SABCS offers physicians and allied health professionals an environment conducive to the exchange of ideas and discussion around current trends in breast cancer research.

This is an excellent opportunity to meet with others passionate about breast health care, as well as to learn about new ways we can help patients. At this year’s SABCS, I am excited to learn more about the results of a trial investigating the use of radiation therapy, new markers for identifying cancer in the blood, advances in genetic […]

SABCS 2014: Estrogen Receptor Positive Treatments & More

The San Antonio Breast Cancer Symposium (SABCS) is one of the world’s premier forums on breast cancer prevention, screening and treatments. Leading experts on breast cancer from various backgrounds gather every year at the SABCS in an effort to promote discussion and education around current trends in breast cancer research.

Now in its 37th year, one of the major focuses of the 2014 SABCS will be on estrogen receptor positive breast cancer. For those interested in developments in this area and others, here is what to watch for.

San Antonio Breast Cancer Symposium 2014

Estrogen Receptor Positive Breast Cancers

In year’s past, HER2-positive breast cancers have been […]

The Importance of Breast Cancer Research

First Annual CRC Charity Golf Tournament

The Importance of Breast Cancer Research: proceeds of the first Cancer Research Collaboration Charity (CRC) Golf Tournament will be used to support ongoing efforts of the CRC and its partners to fight cancer.

The Cancer Research Collaboration is currently preparing to host its first annual CRC Charity Golf Tournament in Mission Viejo. A great chance for golfers to play a round while supporting a worthy cause and for other supporters to engage during a dinner reception, the event is sure to be a hit.

However, while we wait for the fun to begin, it is important to take a moment to remember why […]

By | September 5, 2014|Categories: Cancer Research|Tags: |0 Comments

Kadcyla Research Shows Promise in HER2 Positive Breast Cancer Treatment

Recent research into modern breast cancer therapies have driven major breakthroughs in antibody-drug conjugates, or “smart drugs,” which work by targeting cancer cells while minimizing damage to healthy body tissue.

Kadcyla, also known ado-trastuzumab emtansine (T-DM1), is one of the latest “smart drugs” 
to be FDA-approved in the treatment of women diagnosed with metastatic HER2-positive breast cancer. Kadcyla may also have potential as therapy after surgery where intent is curative.

Breastlink participated in the EMILIA trial, a key clinical trial that helped lead to swift approval of Kadcyla for HER2-positive advanced breast cancer. We also are participating in other ongoing trials to investigate additional uses for Kadcyla in […]

By | July 28, 2014|Categories: Cancer Research, Oncology|0 Comments

Review of the 2013 SABCS

Bevacizumab | 2013 SABCS | BreastlinkThe San Antonio Breast Cancer Symposium (SABCS) is an annual international conference directed towards academicians, private physicians and researchers with more than 7,000 in attendance from 90 countries. The purpose of the symposium is to relay breaking news, trial updates, advances in biology and practice-changing guidelines in breast cancer care and management.

Breastlink sends a team of physicians and researchers to SABCS every year to gather critical updates and research advances. We then disseminate the results to patients, referring physicians and the Breastlink medical team. Last year, for example, the results of the ATLAS trial delivered at the 2012 […]

By | February 3, 2014|Categories: Cancer News, Cancer Research|Tags: , |0 Comments

SABCS 2013 – Anastrozole

The 2013 San Antonio Breast Cancer Symposium was an engaging and invigorating event – I look forward to sharing what I have learned with colleagues and patients. If you have any specific questions you would like me to address about this year’s Symposium please feel free to leave a comment to this blog post or contact my office.

Dr. Nimmi Kapoor and I will also be sharing our observations from this year’s San Antonio Breast Cancer Symposium in a series of community lectures in January. We will share details when they are confirmed.

Here are a few observations from the plenary sessions I attended on Thursday and Friday.

Anastrozole May Provide New Option […]

By | December 17, 2013|Categories: Cancer Research, Oncology|Tags: , |0 Comments

2013 SABCS: Bisphosphonate Therapy | Anastrozole

The 2013 San Antonio Breast Cancer Symposium (SABCS) presented many studies that will change how medical professionals screen, diagnose and treat for breast cancer. The following are a few observations from the SABCS 2013 I think women and fellow medical professionals might be interested in.

Adjuvant Bisphosphonate Therapy in Breast Cancer

The meta-analysis of bisphosphonate treatment presented on Thursday will be practice changing. The Overview Analysis evaluated the benefit of bisphosphonates (such as Zometa) in all randomized trials including more than 17,000 women with breast cancer with 15-year follow-up.

Bisphosphonates given at the start of treatment to post-menopausal women with breast cancer can decrease bone recurrence by 34 percent and can significantly decrease […]

By | December 16, 2013|Categories: Cancer Research, Oncology|Tags: |0 Comments
Load More Posts